SCHEMBL650750

SCHEMBL650750

CCCCn1c(-c2ccccc2)nc(-c2ccc(F)c(F)c2)c1CN(Cc1ccc(OC(F)F)cc1)Cc1cccc(OCC)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.36
C5AR1 P21730 1/20 0.36
ALDH1A1 P00352 1/20 0.35
HTT P42858 1/20 0.35
PPARG P37231 5/20 0.34
PPARA Q07869 5/20 0.34
PPARD Q03181 1/20 0.34
BCHE P06276 3/20 0.33
GRIN1 Q05586 1/20 0.32
GRIN2B Q13224 1/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALOX15 P16050 1/20 0.32
MAPK1 P28482 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL649822 0.94 C5AR1 (0.39) MAPTC5AR1ALDH1A1HTTPPARG
SCHEMBL649888 0.93 C5AR1 (0.40) MAPTC5AR1ALDH1A1HTTPPARG
SCHEMBL650072 0.93 C5AR1 (0.41) MAPTC5AR1ALDH1A1HTTPPARG
SCHEMBL648175 0.93 C5AR1 (0.39) MAPTC5AR1ALDH1A1HTTPPARG
SCHEMBL650506 0.93 C5AR1 (0.37) MAPTC5AR1ALDH1A1HTTPPARG
SCHEMBL647750 0.93 C5AR1 (0.39) MAPTC5AR1ALDH1A1HTTTSHR
SCHEMBL650511 0.93 MAPT (0.41) MAPTC5AR1ALDH1A1PPARGPPARA
SCHEMBL650991 0.92 TLR7 (0.38) MAPTC5AR1ALDH1A1HTTPPARG
SCHEMBL648391 0.92 C5AR1 (0.38) MAPTC5AR1ALDH1A1HTTPPARG
SCHEMBL652368 0.92 C5AR1 (0.39) MAPTC5AR1ALDH1A1HTTPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed